Zacks Investment Research on MSN
Will NovoCure (NVCR) report negative earnings next week? What you should know
The market expects NovoCure (NVCR) to deliver a year-over-year increase in earnings on higher revenues when it reports ...
The sudden death of Thoroughbred trainer John Shirreffs put a capper on a very difficult week for horse racing in the U.S.
Zacks Investment Research on MSN
Collegium Pharmaceutical (COLL) earnings expected to grow: What to know ahead of next week's release
The market expects Collegium Pharmaceutical (COLL) to deliver a year-over-year increase in earnings on higher revenues when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results